MedPath
TGA Approval

ROPIVACAINE KABI ropivacaine hydrochloride 200 mg/20 mL solution for injection ampoule (195809)

195809

ROPIVACAINE KABI ropivacaine hydrochloride 200 mg/20 mL solution for injection ampoule

Fresenius Kabi Australia Pty Ltd

June 13, 2013

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/226c98ae2f0775f06a95d5e34636af70.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/854bd5b0219721fe85c3cde27104b31e.pdf

Active Ingredients

ropivacaine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ROPIVACAINE KABI ropivacaine hydrochloride 200 mg/20 mL solution for injection ampoule (195809) - TGA 批准文号 | MedPath